European Journal of Cancer
Volume 42, Issue 5 , Pages 608-616, March 2006

Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients

  • Carlo Garufi

      Affiliations

    • Department of Medical Oncology, Istituto Regina Elena, Via Chianesi, 53, 00144 Rome, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 6 52666222; fax: +39 6 52666219.
  • ,
  • Barbara Vanni

      Affiliations

    • Department of Medical Oncology, Istituto Regina Elena, Via Chianesi, 53, 00144 Rome, Italy
  • ,
  • Anna Maria Aschelter

      Affiliations

    • Department of Medical Oncology, Istituto Regina Elena, Via Chianesi, 53, 00144 Rome, Italy
  • ,
  • Albina Rita Zappalà

      Affiliations

    • Department of Medical Oncology, Istituto Regina Elena, Via Chianesi, 53, 00144 Rome, Italy
  • ,
  • Emilio Bria

      Affiliations

    • Department of Medical Oncology, Istituto Regina Elena, Via Chianesi, 53, 00144 Rome, Italy
  • ,
  • Cecila Nisticò

      Affiliations

    • Department of Medical Oncology, Istituto Regina Elena, Via Chianesi, 53, 00144 Rome, Italy
  • ,
  • Isabella Sperduti

      Affiliations

    • Biostatistic Unit, Istituto Regina Elena, Rome, Italy
  • ,
  • Francesco Cognetti

      Affiliations

    • Department of Medical Oncology, Istituto Regina Elena, Via Chianesi, 53, 00144 Rome, Italy
  • ,
  • Edmondo Terzoli

      Affiliations

    • Department of Medical Oncology, Istituto Regina Elena, Via Chianesi, 53, 00144 Rome, Italy

Received 25 February 2005; accepted 1 March 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(05)00220-0

doi:10.1016/j.ejca.2005.03.012

European Journal of Cancer
Volume 42, Issue 5 , Pages 608-616, March 2006